Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials
… has remained the primary antithrombotic therapy for the prevention of periprocedural … to 300 s in diabetic patients (Figure 3). Assessment of outcomes in the diabetic population when …..... Read More